PHILADELPHIA, PA — IntegriChain has filled more than half the available capacity for its 2026 Access Insights Conference ahead of the Oct. 19-21 event in Washington, D.C., extending attendance growth as pharmaceutical companies contend with pricing pressure, regulatory shifts and increasingly complex drug launches.
The Philadelphia-based pharmaceutical revenue technology and consulting company limits attendance at the annual conference, which sold out for the first time in 2025 after reaching record participation, according to IntegriChain.
This year’s event, scheduled for the Mayflower Hotel, is designed for pharmaceutical market-access, finance, commercial and operations executives involved in bringing drugs to market.
Programming will cover regulatory policy, pricing strategy and commercialization operations, including pre-launch planning, patient access and management of net revenue.
“We saw record attendance last year, and the response to 2026 has exceeded that pace,” IntegriChain Chief Executive Officer Josh Halpern stated. “Manufacturers are telling us the same thing: they need a room where policy, pricing, and operations are discussed together, not in silos.”
The company reported that more than 50% of available registrations have already been claimed, putting this year’s event ahead of the pace that led to the 2025 sellout.
IntegriChain intentionally caps attendance rather than expanding capacity as registrations increase, according to Bill Roth, senior vice president of consulting and advisory.
“When we sell out, we sell out and demand has been increasing year over year,” Roth stated.
The conference is supported by commercial sponsors, with GiftHealth serving as the exclusive Titanium Sponsor and PHIL, Medfuse, Courier Health and BioCareSD participating as Gold Sponsors.
Access Insights 2026 runs Oct. 19 through Oct. 21. Pharmaceutical manufacturers can register at https://web.cvent.com/event/57b7ae87-1bc6-468b-be63-450da650da35/summary.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.